Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MBD1 antibody (C-Term)

MBD1 Reactivity: Human WB Host: Rabbit Polyclonal RB2371 unconjugated
Catalog No. ABIN1882100
  • Target See all MBD1 Antibodies
    MBD1 (Methyl-CpG Binding Domain Protein 1 (MBD1))
    Binding Specificity
    • 15
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    AA 376-405, C-Term
    Reactivity
    • 42
    • 19
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Human
    Host
    • 33
    • 9
    Rabbit
    Clonality
    • 35
    • 7
    Polyclonal
    Conjugate
    • 24
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This MBD1 antibody is un-conjugated
    Application
    • 34
    • 14
    • 13
    • 13
    • 6
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This MBD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 376-405 amino acids from the C-terminal region of human MBD1.
    Clone
    RB2371
    Isotype
    Ig Fraction
    Top Product
    Discover our top product MBD1 Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Auriol, Billard, Magdinier, Dante: "Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus." in: Nucleic acids research, Vol. 33, Issue 13, pp. 4243-54, (2005) (PubMed).

  • Target
    MBD1 (Methyl-CpG Binding Domain Protein 1 (MBD1))
    Alternative Name
    MBD1 (MBD1 Products)
    Synonyms
    CXXC3 antibody, PCM1 antibody, RFT antibody, Cxxc3 antibody, CCDC11 antibody, methyl-CpG binding domain protein 1 antibody, MBD1 antibody, Mbd1 antibody
    Background
    DNA methylation, or the addition of methyl groups to cytosine bases in the dinucleotide CpG, is imperative to proper development and regulates gene expression. The methylation pattern involves the enzymatic processes of methylation and demethylation. The demethylation enzyme was recently found to be a mammalian protein, which exhibits demethylase activity associated to a methyl-CpG-binding domain (MBD) (1). The enzyme is able to revert methylated cytosine bases to cytosines within the particular dinucleotide sequence mdCpdG by catalyzing the cleaving of the methyl group as methanol. MeCP2 and MBD1 (PCM1) are first found to repress transcription by binding specifically to methylated DNA (2). MBD2 and MBD4 (also known as MED1) were later found to colocalize with foci of heavily methylated satellite DNA and believed to mediate the biological functions of the methylation signal. Surprisingly, MBD3 does not bind methylated DNA both in vivo and in vitro. MBD1, MBD2, MBD3, and MBD4 are found to be expressed in somatic tissues, but the expression of MBD1 and MBD2 is reduced or absent in embryonic stem cells, which are known to be deficient in MeCP1 activity. MBD4 have homology to bacterial base excision repair DNA N-glycosylases/lyases (3). In some microsatellite unstable tumors MBD4 is mutated at an exonic polynucleotide tract (4).
    Molecular Weight
    66607
    NCBI Accession
    NP_001191065, NP_001191066, NP_001191067, NP_001191068, NP_001191069, NP_001191070, NP_001191071, NP_001191072, NP_001191080, NP_002375, NP_056669, NP_056670, NP_056671, NP_056723
    UniProt
    Q9UIS9
You are here:
Support